Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Amplia Therapeutics ( (AU:ATX) ) has issued an announcement.
Amplia Therapeutics Limited has announced a change in the interests of a substantial holder, Acorn Capital Limited, which acts as an investment manager for various superannuation funds, institutional investor portfolios, and unit trusts. This change affects the voting power and number of securities held by Acorn Capital in Amplia Therapeutics. The announcement reflects a decrease in voting power from 8.91% to 7.70%, indicating a shift in Acorn Capital’s stake in the company, which may influence the company’s shareholder dynamics and decision-making processes.
More about Amplia Therapeutics
Average Trading Volume: 2,267,737
Technical Sentiment Signal: Sell
Current Market Cap: A$25.6M
See more insights into ATX stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue